| 1. |
李偲偲. Graves病~(131)碘治療后甲減患者的心理干預研究進展[J]. 醫學信息, 2007, 20(9):1717-1719.
|
| 2. |
李一璐, 魏薇萍. 放射性核素131I治療甲狀腺癌患者心理護理現狀與進展[J]. 齊魯護理雜志, 2012, 18(9):39-41.
|
| 3. |
覃彩燕, 王小玲. 131I治療分化型甲狀腺癌的護理[J]. 廣西醫科大學學報, 2007, 9(S2):103-104.
|
| 4. |
Liu B, Kuang A, Huang R, et al. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patient:a prospective, randomized, single-blind, controlled trial[J]. J Nucl Med, 2010, 51(4):618-623.
|
| 5. |
安小利, 高玉花, 汪靜. 分化型甲狀腺癌術后131I治療的輻射防護[J]. 現代腫瘤醫學, 2014, 22(1):51-53.
|
| 6. |
李傳瓊, 崔邦平, 代文莉, 等. 分化型甲狀腺癌患者131I治療的輻射防護護理干預[J]. 海南醫學, 2012, 23(23):143-144.
|
| 7. |
Zaman M, Fatima N, Padhy AK, et al. Controversies about radioactive iodine-131 remnant ablation in low risk thyroid cancers:are we near a consensus?[J]. Asian Pac J Cancer Prev, 2013, 14(11):6209-6213.
|
| 8. |
Lee J, Yun MJ, Nam KH, et al. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma[J]. Thyroid, 2010, 20(2):173-179.
|
| 9. |
Meng LW, Hu S, Huang LM, et al. Papillary thyroid cancer coexisting with thyroid tuberculosis:a case report[J]. Oncol Lett, 2014, 7(5):1563-1565.
|
| 10. |
Wang QC, Cheng W, Wen X, et al. Shorter distance between the nodule and capsule has greater risk of cervical lymph node metastasis in papillary thyroid carcinoma[J]. Asian Pac J Cancer Prev, 2014, 15(2):855-860.
|
